Phospho-Paxillin (Ser178) Antibody - #AF3835
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# AF3835, RRID:AB_2847149.
折りたたみ/展開
FLJ16691; FLJ23042; Paired box protein Pax 1; PAX 1; PAX1; PAXI_HUMAN; Paxillin alpha; Paxillin; PXN; PXN protein;
免疫原
A synthesized peptide derived from human Paxillin around the phosphorylation site of Ser178.
- P49023 PAXI_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MDDLDALLADLESTTSHISKRPVFLSEETPYSYPTGNHTYQEIAVPPPVPPPPSSEALNGTILDPLDQWQPSSSRFIHQQPQSSSPVYGSSAKTSSVSNPQDSVGSPCSRVGEEEHVYSFPNKQKSAEPSPTVMSTSLGSNLSELDRLLLELNAVQHNPPGFPADEANSSPPLPGALSPLYGVPETNSPLGGKAGPLTKEKPKRNGGRGLEDVRPSVESLLDELESSVPSPVPAITVNQGEMSSPQRVTSTQQQTRISASSATRELDELMASLSDFKIQGLEQRADGERCWAAGWPRDGGRSSPGGQDEGGFMAQGKTGSSSPPGGPPKPGSQLDSMLGSLQSDLNKLGVATVAKGVCGACKKPIAGQVVTAMGKTWHPEHFVCTHCQEEIGSRNFFERDGQPYCEKDYHNLFSPRCYYCNGPILDKVVTALDRTWHPEHFFCAQCGAFFGPEGFHEKDGKAYCRKDYFDMFAPKCGGCARAILENYISALNTLWHPECFVCRECFTPFVNGSFFEHDGQPYCEVHYHERRGSLCSGCQKPITGRCITAMAKKFHPEHFVCAFCLKQLNKGTFKEQNDKPYCQNCFLKLFC
PTMs - P49023 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
M1 | Acetylation | Uniprot | |
T29 | Phosphorylation | Uniprot | |
Y31 | Phosphorylation | A0A059VC25 (FAK) , Q13882 (PTK6) , P00519 (ABL1) , Q05397 (PTK2) | Uniprot |
S32 | Phosphorylation | Uniprot | |
Y33 | Phosphorylation | Uniprot | |
T35 | Phosphorylation | Uniprot | |
T39 | Phosphorylation | Uniprot | |
Y40 | Phosphorylation | P12931 (SRC) | Uniprot |
S83 | Phosphorylation | Uniprot | |
S84 | Phosphorylation | Uniprot | |
S85 | Phosphorylation | Q16539 (MAPK14) , Q00535 (CDK5) | Uniprot |
Y88 | Phosphorylation | P12931 (SRC) | Uniprot |
S90 | Phosphorylation | Uniprot | |
S95 | Phosphorylation | Uniprot | |
S103 | Phosphorylation | Uniprot | |
S106 | Phosphorylation | Uniprot | |
C108 | S-Nitrosylation | Uniprot | |
S109 | Phosphorylation | Uniprot | |
Y118 | Phosphorylation | P00519 (ABL1) , Q05397 (PTK2) , Q13882 (PTK6) , A0A059VC25 (FAK) | Uniprot |
S119 | Phosphorylation | Uniprot | |
K123 | Ubiquitination | Uniprot | |
K125 | Ubiquitination | Uniprot | |
S126 | Phosphorylation | Q9UBE8 (NLK) | Uniprot |
S130 | Phosphorylation | P27361 (MAPK3) | Uniprot |
T132 | Phosphorylation | Uniprot | |
S135 | Phosphorylation | Uniprot | |
T136 | Phosphorylation | Uniprot | |
S137 | Phosphorylation | Uniprot | |
S140 | Phosphorylation | Uniprot | |
S143 | Phosphorylation | Uniprot | |
S178 | Phosphorylation | P45983 (MAPK8) | Uniprot |
Y181 | Phosphorylation | Uniprot | |
S188 | Phosphorylation | Uniprot | |
S219 | Phosphorylation | Uniprot | |
S230 | Phosphorylation | Uniprot | |
S243 | Phosphorylation | Uniprot | |
S244 | Phosphorylation | Uniprot | |
T249 | Phosphorylation | Uniprot | |
S250 | Phosphorylation | Uniprot | |
T251 | Phosphorylation | Uniprot | |
T255 | Phosphorylation | Uniprot | |
S258 | Phosphorylation | Q13153 (PAK1) | Uniprot |
S260 | Phosphorylation | Uniprot | |
S261 | Phosphorylation | Uniprot | |
T263 | Phosphorylation | Uniprot | |
S272 | Phosphorylation | Q13177 (PAK2) , O96013 (PAK4) , Q13153 (PAK1) | Uniprot |
S274 | Phosphorylation | Q13177 (PAK2) | Uniprot |
K277 | Ubiquitination | Uniprot | |
S302 | Phosphorylation | Uniprot | |
S303 | Phosphorylation | Uniprot | |
T318 | Phosphorylation | Uniprot | |
S320 | Phosphorylation | Uniprot | |
S321 | Phosphorylation | Uniprot | |
S322 | Phosphorylation | Uniprot | |
S332 | Phosphorylation | Uniprot | |
S336 | Phosphorylation | Uniprot | |
S340 | Phosphorylation | Uniprot | |
K355 | Ubiquitination | Uniprot | |
T371 | Phosphorylation | Uniprot | |
Y409 | Phosphorylation | Uniprot | |
S414 | Phosphorylation | Uniprot | |
Y468 | Phosphorylation | Uniprot | |
S533 | Phosphorylation | Uniprot | |
K540 | Ubiquitination | Uniprot |
研究背景
Cytoskeletal protein involved in actin-membrane attachment at sites of cell adhesion to the extracellular matrix (focal adhesion).
Phosphorylated by MAPK1/ERK2 (By similarity). Phosphorylated on tyrosine residues during integrin-mediated cell adhesion, embryonic development, fibroblast transformation and following stimulation of cells by mitogens. Phosphorylation at Ser-244 by CDK5 reduces its interaction with PTK2/FAK1 in matrix-cell focal adhesions (MCFA) during oligodendrocytes (OLs) differentiation. Phosphorylation at Tyr-31 and Tyr-118 by PTK6 promote the activation of RAC1 via CRK/CrKII, thereby promoting migration and invasion. Phosphorylation at Ser-250 by SLK is required for PXN redistribution and cell motility.
Cytoplasm>Cytoskeleton. Cell junction>Focal adhesion. Cytoplasm>Cell cortex.
Note: Colocalizes with integrins at the cell periphery. Colocalize with PXN to membrane ruffles and the leading edge of migrating cells (PubMed:23128389).
Binds in vitro to vinculin as well as to the SH3 domain of SRC and, when tyrosine phosphorylated, to the SH2 domain of V-CRK. Isoform beta binds to PTK2/FAK1 but weakly to vinculin. Isoform gamma binds to vinculin but only weakly to PTK2/FAK1. Interacts with GIT1, NUDT16L1/SDOS and TGFB1I1. Component of cytoplasmic complexes, which also contain GIT1, ARHGEF6 and PAK1. Interacts with PTK2/FAK1 and PTK2B/PYK2. Binds ASAP2. Interacts with unphosphorylated ITGA4. Interacts with RNF5 and PDCD10. Interacts with NEK3 and this interaction is prolactin-dependent. Interacts with PTK6. Interacts with SORBS1, PARVA and PARVB. Interacts (via cytoplasmic domain) with CEACAM1; the interaction is phosphotyrosyl-dependent. Interacts with LIMA1; this complex stabilizes actin dynamics.
Belongs to the paxillin family.
研究領域
· Cellular Processes > Cellular community - eukaryotes > Focal adhesion. (View pathway)
· Cellular Processes > Cell motility > Regulation of actin cytoskeleton. (View pathway)
· Human Diseases > Infectious diseases: Bacterial > Bacterial invasion of epithelial cells.
· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.
· Human Diseases > Cancers: Overview > Viral carcinogenesis.
· Human Diseases > Cancers: Overview > Proteoglycans in cancer.
· Organismal Systems > Immune system > Chemokine signaling pathway. (View pathway)
· Organismal Systems > Immune system > Leukocyte transendothelial migration. (View pathway)
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.